Microbes Turn Plastic into Biscuits and Painkillers!
In two developments that are fundamentally intertwined, research teams in the United States and the United Kingdom have revealed the remarkable ability of genetically modified microbes to convert plastic bottle waste into products suitable for human consumption and use, including vanilla-flavored, protein-rich biscuits and painkillers from the paracetamol class. Thus, plastic waste is becoming qualified to transition from being merely an environmental pollutant to a potential source of food and medicine, in a world groaning under the weight of pollution and resource scarcity.
During the American Chemical Society’s Fall 2026 meeting in August, researchers from Southern Illinois University Carbondale presented a technology that converts PET bottles and corn waste into vanilla-flavored protein biscuits. The process relies on “hydrothermal oxidation,” a technique developed by Professor Ken Anderson, in which plastic and agricultural waste are broken down under high heat and pressure into a carbon-rich mixture, which is then metabolized by genetically modified yeasts. One strain converts the biomass into vanilla flavor, while another converts ethylene glycol, a byproduct of PET degradation, into beta-carotene (a precursor to vitamin A). The mixture is then shaped using 3D printing technology and hardened in a microwave. The final product is completely free of plastic and scored 6.5 out of 9 on the standard taste scale.
Preliminary results indicate that carbon conversion rates exceed 50 percent of the waste within one to two days, while production costs currently stand at approximately $60 per kilogram. Independent laboratory tests confirm that the product is free of toxins, heavy metals, and allergens, although institutional approval for formal testing remains pending.
In a parallel development, a team led by Professor Stephen Wallace from the University of Edinburgh revealed a method by which genetically modified Escherichia coli bacteria convert disassembled PET bottle waste into the active ingredient in common painkillers such as Tylenol and Panadol, in a study published in the journal Nature Chemistry.
The genetically modified bacteria were able to convert 92 percent of the disassembled plastic waste into paracetamol within just 48 hours. The pivotal step relies on a chemical reaction known as the “Lucas rearrangement” within living cells, achieved for the first time, opening a more sustainable pathway for drug manufacturing that reduces reliance on fossil fuels.
• Feedstock: Discarded PET bottles combined with agricultural waste (corn and its leaves) in the biscuit project, and disassembled plastic waste in the drug project.
• Efficiency: Carbon conversion exceeds 50 percent within two days for the biscuits, and 92 percent for the drug within 48 hours.
These two projects share a unified scientific vision: transforming plastic waste from an environmental burden into a valuable resource. The biscuit project, which began as a food experiment for NASA in the “Food in Deep Space” challenge, aims to address the anticipated food shortage by 2050 (with demand expected to rise by 35–56 percent and 30 percent of the world’s population at risk of hunger). Meanwhile, the paracetamol project seeks to provide sustainable alternatives for pharmaceutical industries reliant on fossil fuels.
Researchers, including Lahiri Jayakody and Stephen Wallace, acknowledge that the road ahead is long. Scaling up laboratory processes to an industrial level remains difficult, and the instinctive aversion to the idea of “plastic biscuits” or “medicine from waste” will take time to overcome, much like the initial reception of lab-grown meat.
Experts view these foundational studies as “a step in the right direction,” noting that the mere transformation of “waste,” “food,” and “medicine” into interconnected research topics is, in itself, an achievement worth highlighting. They emphasize that future environmental solutions may emerge from unexpected quarters: within laboratories that are redefining what we eat and the medicines we consume.
